Biotechnology R&D (Except Nanobiotechnology) in Maryland (NAICS 541714)

Maryland and NAICS 541714 as a biotech-R&D join

NAICS 541714 and place-of-performance state MD meet on this tie. $106,988,198.72 is the obligation sum on awards that carry both tags. It is not Maryland's statewide federal total, not an outlay, and not a national 541714 roll-up. The NAICS title excepts nanobiotechnology; that excepted line is not rolled into $106,988,198.72 if coded to its own key.

196 is an award-action count. Unique labs and primes are unpublished. The join does not rank Maryland against other states and does not assign a fiscal year; none is in the facts.

Open Maryland federal spending for the state rollup, NAICS 541714 for the industry hub, Maryland industries for other NAICS in the same geography, and All spending ties for other pairs.

Biotechnology R&D except nanobiotechnology

USAspending labels NAICS 541714 as Research And Development In Biotechnology (Except Nanobiotechnology). Physical, engineering, and life sciences R&D except nanotechnology and biotechnology is a different six-digit key. Sharing an R&D vocabulary does not merge those codes into $106,988,198.72. The industry hub for NAICS 541714 does not require Maryland.

The packet names no laboratories, agencies, or primes. Award titles on the NAICS 541714 page are the place to see what a given line bought. Do not treat the overlay as a statewide biotech-campus census.

Place of performance in Maryland

Maryland on this join is a geography field, not a Bethesda-only overlay. Awards can list MD while later laboratory work occurs in another state; those states are not inside this total unless also coded MD. The packet does not split counties or congressional districts.

The state hub for Maryland shows how 541714 sits beside other industries with MD place of performance. Awards can list Maryland while headquarters sit elsewhere.

196 awards behind $106,988,198.72

Dividing $106,988,198.72 by 196 yields about $545,858 per award on average. That ratio is packet arithmetic, not a typical research invoice. Award count 196 is a record count, not a payment count. Readers who need transaction-level detail should use Maryland industries and the NAICS 541714 hub.

An obligation is a legal commitment. $106,988,198.72 is that kind of sum. This packet has no outlay total. Citing the figure as cash already spent in Maryland laboratories over-reads the field.

What the 541714–Maryland pair does not prove

A biotechnology-R&D NAICS plus Maryland is not a science ranking and is not a claim that campaign contributions funded the awards. FEC filings and USAspending awards are different datasets. Keep $106,988,198.72 labeled as NAICS 541714 obligations with Maryland place of performance.

A later ingest can restate the dollars or the 196 count without changing the join key of NAICS 541714 and MD. Correlation is not causation.

How to read the Maryland biotech-R&D hubs

Readers who only need the headline can stop at NAICS 541714 in Maryland: $106,988,198.72 across 196 awards. Nothing in the packet supports a contractor roster or a fiscal-year split.

Maryland's 541714 cell is biotechnology R&D except nanobiotechnology. 196 awards and $106,988,198.72 stay on this R&D join. Use Maryland federal spending and NAICS 541714 for the parent rollups.

Reuse $106,988,198.72 only with Research And Development In Biotechnology (Except Nanobiotechnology) and Maryland in the same citation. Original filings remain on USAspending.gov.

Quote both keys when you reuse the figure: NAICS 541714 (Research And Development In Biotechnology (Except Nanobiotechnology)) and Maryland place of performance. $106,988,198.72 is the intersection, not a parent rollup. 196 awards against $106,988,198.72 is a mid-count research and development in biotechnology (except nanobiotechnology) file in Maryland. The mean of about $545,858 is packet arithmetic, not a typical invoice. The four hubs—Maryland federal spending, NAICS 541714, Maryland industries, and All spending ties—are larger than this cell and should not be added into $106,988,198.72.

This extract publishes no outlay total, no fiscal-year split, no unique-vendor count, and no named contractors. Place of performance MD does not locate a county or a facility. Keep FEC contribution tables off this page; they do not fund these USAspending obligations. Original filings remain on USAspending.gov. Readers comparing Maryland to other states should use the NAICS 541714 hub, which is not filtered to MD, rather than treat $106,988,198.72 as a ranking.

Questions

How much has NAICS 541714 obligated in Maryland?

USAspending.gov records $106,988,198.72 in obligations for NAICS 541714 (Research And Development In Biotechnology (Except Nanobiotechnology)) with Maryland place of performance, covering 196 awards. That is an obligation total, not an outlay total. Original filings remain on USAspending.gov.

Does this include nanobiotechnology R&D in Maryland?

Not under this key. NAICS 541714 excepts nanobiotechnology. The $106,988,198.72 and 196 awards here do not absorb that excepted line. Original filings remain on USAspending.gov. Cite $106,988,198.72 only with NAICS 541714 and Maryland place of performance. Unique vendors are unpublished.

Do 196 awards mean 196 biotech labs in Maryland?

No. The extract lists 196 awards totaling $106,988,198.72. Modifications can multiply rows. Unique vendors are unpublished. Original filings remain on USAspending.gov. Cite $106,988,198.72 only with NAICS 541714 and Maryland place of performance. Unique vendors are unpublished.

Where is the live biotech-R&D–Maryland table?

Maryland federal spending is the state rollup. NAICS 541714 is the industry hub without a state filter. Maryland industries lists other NAICS in Maryland. All spending ties lists other pairs. The $106,988,198.72 and 196 awards are the 541714×MD join only. Original filings remain on USAspending.gov.